{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T07:16:14Z","timestamp":1793776574704,"version":"4.6.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.msard.2022.103723","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T20:05:27Z","timestamp":1646424327000},"page":"103723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis"],"prefix":"10.1016","volume":"60","author":[{"given":"Naghmeh","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Ghadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdorreza Naser","family":"Moghadasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirreza","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Navardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hora","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Karaminia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ali","family":"Sahraian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2022.103723_bib0001","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/v12020135","article-title":"Return of the coronavirus: 2019-nCoV","volume":"12","author":"Gralinski","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.msard.2022.103723_bib0002","unstructured":"https:\/\/www.who.int\/news-room\/q-a-detail\/herd-immunity-lockdowns-and-COVID-19 2022."},{"issue":"9","key":"10.1016\/j.msard.2022.103723_bib0003","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s40263-020-00756-y","article-title":"Multiple sclerosis disease-modifying therapy and the COVID-19 pandemic: implications on the risk of infection and future vaccination","volume":"34","author":"Zheng","year":"2020","journal-title":"CNS Drugs"},{"key":"10.1016\/j.msard.2022.103723_bib0004","unstructured":"https:\/\/www.nationalmssociety.org\/coronavirus-COVID-19-information\/multiple-sclerosis-and-coronavirus\/COVID-19-vaccine-guidance 2022."},{"issue":"8","key":"10.1016\/j.msard.2022.103723_bib0005","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10654-020-00671-y","article-title":"Vaccine hesitancy: the next challenge in the fight against COVID-19","volume":"35","author":"Dror","year":"2020","journal-title":"Eur. J. Epidemiol."},{"issue":"34","key":"10.1016\/j.msard.2022.103723_bib0006","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1016\/j.vaccine.2015.04.036","article-title":"Vaccine hesitancy: definition, scope and determinants","volume":"33","author":"MacDonald","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.msard.2022.103723_bib0007","doi-asserted-by":"crossref","first-page":"n26","DOI":"10.1136\/bmj.n26","article-title":"Too little, too late: social media companies\u2019 failure to tackle vaccine misinformation poses a real threat","volume":"372","author":"Wardle","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.msard.2022.103723_bib0008","doi-asserted-by":"crossref","first-page":"e991","DOI":"10.1212\/NXI.0000000000000991","article-title":"Vaccine hesitancy in patients with multiple sclerosis: preparing for the SARS-CoV-2 vaccination challenge","volume":"8","author":"Diem","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.msard.2022.103723_bib0009","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/brainsci11070890","article-title":"Influenza vaccine hesitancy in patients with multiple sclerosis: a monocentric observational study","volume":"11","author":"Ziello","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.msard.2022.103723_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102788","article-title":"Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States","volume":"49","author":"Ehde","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103723_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103236","article-title":"Vaccine hesitancy among people with multiple sclerosis","volume":"56","author":"Yap","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103723_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103163","article-title":"COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: a follow up survey during the initial vaccine rollout in 2021","volume":"54","author":"Ehde","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"2","key":"10.1016\/j.msard.2022.103723_bib0013","article-title":"COVID-19 vaccination willingness among people with multiple sclerosis","volume":"7","author":"Xiang","year":"2021","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2022.103723_bib0014","article-title":"COVID-19 vaccine hesitancy in multiple sclerosis: a cross-sectional survey","author":"Uhr","year":"2021","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.103723_bib0015","article-title":"COVID-19 vaccine intent in appalachian patients with multiple sclerosis","volume":"57","author":"Wu","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103723_bib0016","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fmed.2020.00348","article-title":"Systematic review and meta-analysis of sex-specific COVID-19 clinical outcomes","volume":"7","author":"Galbadage","year":"2020","journal-title":"Front. Med."},{"issue":"19","key":"10.1016\/j.msard.2022.103723_bib0017","doi-asserted-by":"crossref","first-page":"e1870","DOI":"10.1212\/WNL.0000000000012753","article-title":"Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis","volume":"97","author":"Simpson-Yap","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103723_bib0018","unstructured":"https:\/\/www.who.int\/news-room\/feature-stories\/detail\/vaccine-efficacy-effectiveness-and-protection 2022."},{"key":"10.1016\/j.msard.2022.103723_bib0019","unstructured":"https:\/\/www.nature.com\/articles\/d41586-021-03672-3 2022."},{"key":"10.1016\/j.msard.2022.103723_bib0020","unstructured":"https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/variants\/omicron-variant.html 2022."},{"key":"10.1016\/j.msard.2022.103723_bib0021","article-title":"Vaccination against SARS-CoV-2 in neuroinflammatory disease: early safety\/tolerability data","volume":"57","author":"Epstein","year":"2021","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822002383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822002383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:00:17Z","timestamp":1761901217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822002383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":21,"alternative-id":["S2211034822002383"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103723","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 vaccine hesitancy in Iranian patients with multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103723"}}